CHAI tackles AI risks with a work group to address cyber risks in health artificial intelligence models, creating playbooks for organizations.
AMS sale to H B Fuller approved for 715 million pounds, expanding medical earnings before interest.
AI ultrasound tool from DeepHealth gains FDA 510(k) clearance, offering breast scan analysis and draft reports to aid radiologists in detecting lesions.
Robotic microsurgery is being tested for Alzheimer's treatment with FDA clearance for expanded enrollment in a feasibility trial using robotic systems.
Regular coffee intake is linked to lower disease risk, with up to 400 mg of caffeine daily considered safe for most adults,…
Lung cancer treatment raises safety concerns with atezolizumab and consolidative thoracic radiotherapy combination.
New research explores how genetic factors and polygenic risk scores can improve the difficult diagnosis of idiopathic pulmonary fibrosis using real-world medica
MASH predictors reveal cardiovascular and kidney risks that drive rapid liver scarring and soaring healthcare costs, highlighting urgent need for targeted inter
New evidence validates a standardized functional vision assessment for children with cerebral/cortical visual impairment, closing the gap in clinical tools.
Users report unexpected account blocks across platforms, prompting concerns about security and access; discover why these blocks happen and how to resolve…